A typical gout flare lasts 7 to 14 days without treatment. With early treatment, most people see significant pain reduction within the first 24 to 48 hours, and the total flare resolves faster. The severity and duration depend on how quickly you act, how long you’ve had gout, and whether you’re managing your uric acid levels long-term.
Timeline of an Untreated Flare
Gout flares almost always strike suddenly, often in the middle of the night. Many people describe waking up with the sensation that their big toe is on fire. The pain escalates quickly, reaching its worst intensity within the first 4 to 12 hours. During this peak, the affected joint becomes swollen, red, warm, and exquisitely tender. Even the weight of a bedsheet can feel unbearable.
After the peak, the intense pain gradually subsides over several days. Without any medication, full recovery from a single flare takes roughly 7 to 14 days. Even after the worst pain passes, lingering joint tenderness and stiffness can hang around for a few days more before the joint feels completely normal again.
How Treatment Shortens the Flare
Starting treatment within hours of the first symptoms makes a meaningful difference. The earlier you begin, the faster and more completely the flare resolves. In clinical trials, patients who took colchicine (one of the standard treatments) had a 50 percent reduction in pain at 24 hours at more than twice the rate of those on placebo, with measurable pain relief beginning as early as 16 hours after the first dose. Anti-inflammatory pain relievers like naproxen work on a similar timeline, and a seven-day trial comparing the two found no difference in pain intensity by the end of the week.
The key takeaway is speed. A flare that could drag on for two weeks untreated can often be brought under control in a few days when you treat it promptly. Waiting even a day or two to start medication allows the inflammation to build momentum, making it harder to rein in.
Why the Flare Stops on Its Own
Even without treatment, every gout flare eventually burns itself out. The reason comes down to the body’s own cleanup crew. When uric acid crystals trigger inflammation in a joint, the immune system floods the area with white blood cells called neutrophils. These cells engulf the crystals but then die in a specific way: they release web-like structures made of DNA that trap the crystals into dense clumps.
These structures also trap and break down the chemical signals that drive inflammation. Once enough neutrophils accumulate and form large clusters of these traps, the inflammatory signals are effectively destroyed. The inflammation collapses, and the flare ends. This tipping point, where enough immune cells have gathered to shut the process down, is why flares follow a predictable arc of escalation followed by gradual resolution.
How Flares Change Over Time
Early in the disease, most people experience a single flare followed by months or even years of no symptoms at all. This pain-free interval can create a false sense that the problem has resolved. But if uric acid levels remain elevated, crystals continue to accumulate silently in and around joints.
Over time, flares tend to become more frequent, last longer, and involve more joints. What started as an occasional episode in the big toe can progress to attacks in the ankles, knees, wrists, or fingers. In advanced cases, persistent crystal deposits called tophi form visible lumps under the skin, and the inflammation may never fully resolve between flares. At this stage, the condition shifts from intermittent acute attacks to chronic joint disease with ongoing pain and potential joint damage.
Preventing Flares From Recurring
Shortening individual flares matters, but the bigger goal is reducing how often they happen. The American College of Rheumatology recommends keeping blood uric acid levels below 6 mg/dL. At this threshold, existing crystals gradually dissolve over months, and new ones stop forming. Once crystal deposits are cleared, flares stop.
Reaching that target usually requires urate-lowering medication taken daily, not just during flares. Lifestyle adjustments can help at the margins: limiting alcohol (especially beer), reducing red meat and shellfish, staying well hydrated, and maintaining a healthy weight all contribute to lower uric acid. But for most people with recurrent gout, diet alone isn’t enough to get below that 6 mg/dL target.
One common frustration is that starting urate-lowering therapy can actually trigger flares in the first few months. As uric acid levels drop, existing crystal deposits shift and partially dissolve, which can provoke new attacks. This is temporary and doesn’t mean the treatment is failing. Many doctors prescribe a low-dose anti-inflammatory alongside the urate-lowering medication during this adjustment period to reduce the risk of these early flares.